UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2015 UpToDate®

Medline ® Abstract for Reference 90

of 'Treatment of relapsing-remitting multiple sclerosis in adults'

90
 
 
FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod). www.fda.gov/Drugs/DrugSafety/ucm303192.htm (Accessed on May 15, 2012).
 
no abstract available